Freienbach, August 31^st, 2026 – EffRx Pharmaceuticals SA, a Swiss commercial-stage pharmaceutical company focused on the development and commercialization of treatments for endocrine, metabolic and musculoskeletal disorders, announced that it has signed an agreement with Androlabs to commercialize Testavan® in Switzerland. Androlabs is the first global pharmaceutical company solely dedicated to men’s health, with a mission to close the male life expectancy gap. Androlabs partners with healthcare professionals to improve awareness, education, and access to treatments for conditions affecting men.

Testavan® is a testosterone replacement therapy indicated for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests.¹ The product is available in more than 20 countries across Europe, Australia, and the Middle East.

We are pleased to partner with Androlabs to commercialize and distribute Testavan® in Switzerland,” said Victor Papavasileiou, EVP Corporate Development at EffRx Pharmaceuticals. “Testavan® is an important addition to our musculoskeletal portfolio, and this agreement demonstrates our commitment to bringing patient-focused treatments to the Swiss market.”

Nicolas Vennin, co-founder of Androlabs, said: “We look forward to working with EffRx to expand the reach of Testavan in Switzerland and bring choices to patients and prescribers, ultimately advancing men’s health in the country.” 

This collaboration reflects the shared commitment of both companies to supporting healthcare professionals and patients in Switzerland by ensuring sustained access to treatment options for testosterone deficiency.

About EffRx Pharmaceuticals:

EffRx Pharmaceuticals is a Swiss commercial-stage pharmaceutical company focused on the late-stage development and commercialization of medications for niche endocrine, metabolic and musculoskeletal disorders. EffRx is controlled by Abiogen Pharma S.p.A., a leading company in the field of osteoarticular and bone metabolism diseases.

About Androlabs

Androlabs is the first global pharmaceutical company dedicated exclusively to men’s health. Its mission is to close the male life expectancy gap and improve health outcomes for men worldwide.

Reference:

1.Product Information Testavan®, June 2026. Available at:www.swissmedicinfo-pro.ch.

Contacts:

Androlabs

requests@androlabs.com

EffRx Pharmaceuticals

info@effrx.com 

Disclaimer: This communication is intended for institutional purposes and does not constitute promotional or medical communication to the general public.